Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Xue

Showing results (371-380 of 380) with videos related to

Pageof 38
Sort By:
You have reached the last page of results.This site can display upto 380 results.
Animal : an International Journal of Animal Bioscience|January 7, 2025
Genomic insights into the specialisation and selection of the Jinding duckH Chen, Y Huang, J Xue, et al.
Zhonghua Yi Xue Za Zhi|January 17, 2017
[Risk factors for acute rejection in living-donor kidney transplant recipients in China: a subgroup analysis of a multi-center, registry study]X P Hu, Y Tian, T Y Zhu, et al.
Platelets|February 3, 2016
Comparison of half- and standard-dose ticagrelor in Chinese patients with NSTE-ACSH J Xue, J Shi, B Liu, et al.
American Heart Journal|May 14, 2020
Are cost advantages from a modern Indian hospital transferable to the United States?F Erhun, R S Kaplan, V G Narayanan, et al.
The Journal of Investigative Dermatology|March 26, 2014
NOTCH1 mutations occur early during cutaneous squamous cell carcinogenesisAndrew P South, Karin J Purdie, Stephen A Watt, et al.
Cell Death & Disease|January 16, 2015
Potent and selective small-molecule MCL-1 inhibitors demonstrate on-target cancer cell killing activity as single agents and in combination with ABT-263 (navitoclax)J D Leverson, H Zhang, J Chen, et al.
Oncogenesis|February 15, 2017
Integrative analyses of transcriptome sequencing identify novel functional lncRNAs in esophageal squamous cell carcinomaC-Q Li, G-W Huang, Z-Y Wu, et al.
Bioanalysis|December 6, 2017
2017 White Paper: rise of hybrid LBA/LCMS immunogenicity assays (Part 2: hybrid LBA/LCMS biotherapeutics, biomarkers & immunogenicity assays and regulatory agencies' inputs)Hendrik Neubert, An Song, Anita Lee, et al.
Bioanalysis|May 17, 2022
2021 White Paper on Recent Issues in Bioanalysis: Mass Spec of Proteins, Extracellular Vesicles, CRISPR, Chiral Assays, Oligos; Nanomedicines Bioanalysis; ICH M10 Section 7.1; Non-Liquid & Rare Matrices; Regulatory Inputs (<u>Part 1A</u> - Recommendations on Endogenous Compounds, Small Molecules, Complex Methods, Regulated Mass Spec of Large Molecules, Small Molecule, PoC & <u>Part 1B</u> - Regulatory Agencies' Inputs on Bioanalysis, Biomarkers, Immunogenicity, Gene & Cell Therapy and Vaccine)Surinder Kaur, Stephen C Alley, Matt Szapacs, et al.
Bioanalysis|June 24, 2024
2023 White Paper on Recent Issues in Bioanalysis: Deuterated Drugs; LNP; Tumor/FFPE Biopsy; Targeted Proteomics; Small Molecule Covalent Inhibitors; Chiral Bioanalysis; Remote Regulatory Assessments; Sample Reconciliation/Chain of Custody <u>(PART 1A</u> - Recommendations on Mass Spectrometry, Chromatography, Sample Preparation Latest Developments, Challenges, and Solutions and BMV/Regulated Bioanalysis <u>PART 1B</u> - Regulatory Agencies' Inputs on Regulated Bioanalysis/BMV, Biomarkers/IVD/CDx/BAV, Immunogenicity, Gene & Cell Therapy and Vaccine)Mike Baratta, Wenying Jian, Shawna Hengel, et al.
Pageof 38

Showing results (371-380 of 380) with videos related to

Sort By:
Pageof 38
You have reached the last page of results.This site can display upto 380 results.
Animal : an International Journal of Animal Bioscience|January 7, 2025
Genomic insights into the specialisation and selection of the Jinding duckH Chen, Y Huang, J Xue, et al.
Zhonghua Yi Xue Za Zhi|January 17, 2017
[Risk factors for acute rejection in living-donor kidney transplant recipients in China: a subgroup analysis of a multi-center, registry study]X P Hu, Y Tian, T Y Zhu, et al.
Platelets|February 3, 2016
Comparison of half- and standard-dose ticagrelor in Chinese patients with NSTE-ACSH J Xue, J Shi, B Liu, et al.
American Heart Journal|May 14, 2020
Are cost advantages from a modern Indian hospital transferable to the United States?F Erhun, R S Kaplan, V G Narayanan, et al.
The Journal of Investigative Dermatology|March 26, 2014
NOTCH1 mutations occur early during cutaneous squamous cell carcinogenesisAndrew P South, Karin J Purdie, Stephen A Watt, et al.
Cell Death & Disease|January 16, 2015
Potent and selective small-molecule MCL-1 inhibitors demonstrate on-target cancer cell killing activity as single agents and in combination with ABT-263 (navitoclax)J D Leverson, H Zhang, J Chen, et al.
Oncogenesis|February 15, 2017
Integrative analyses of transcriptome sequencing identify novel functional lncRNAs in esophageal squamous cell carcinomaC-Q Li, G-W Huang, Z-Y Wu, et al.
Bioanalysis|December 6, 2017
2017 White Paper: rise of hybrid LBA/LCMS immunogenicity assays (Part 2: hybrid LBA/LCMS biotherapeutics, biomarkers & immunogenicity assays and regulatory agencies' inputs)Hendrik Neubert, An Song, Anita Lee, et al.
Bioanalysis|May 17, 2022
2021 White Paper on Recent Issues in Bioanalysis: Mass Spec of Proteins, Extracellular Vesicles, CRISPR, Chiral Assays, Oligos; Nanomedicines Bioanalysis; ICH M10 Section 7.1; Non-Liquid & Rare Matrices; Regulatory Inputs (<u>Part 1A</u> - Recommendations on Endogenous Compounds, Small Molecules, Complex Methods, Regulated Mass Spec of Large Molecules, Small Molecule, PoC & <u>Part 1B</u> - Regulatory Agencies' Inputs on Bioanalysis, Biomarkers, Immunogenicity, Gene & Cell Therapy and Vaccine)Surinder Kaur, Stephen C Alley, Matt Szapacs, et al.
Bioanalysis|June 24, 2024
2023 White Paper on Recent Issues in Bioanalysis: Deuterated Drugs; LNP; Tumor/FFPE Biopsy; Targeted Proteomics; Small Molecule Covalent Inhibitors; Chiral Bioanalysis; Remote Regulatory Assessments; Sample Reconciliation/Chain of Custody <u>(PART 1A</u> - Recommendations on Mass Spectrometry, Chromatography, Sample Preparation Latest Developments, Challenges, and Solutions and BMV/Regulated Bioanalysis <u>PART 1B</u> - Regulatory Agencies' Inputs on Regulated Bioanalysis/BMV, Biomarkers/IVD/CDx/BAV, Immunogenicity, Gene & Cell Therapy and Vaccine)Mike Baratta, Wenying Jian, Shawna Hengel, et al.
Pageof 38